Core Insights - The core point of the article is that Innovation Medical (002173) reported a slight decline in revenue for the first three quarters of 2025, but achieved a turnaround in net profit due to the consolidation of its investment in Boling Brain Machine [1] Financial Performance - The company's operating revenue for the first three quarters was 597 million yuan, representing a year-on-year decrease of 2.11% [1] - The net profit attributable to the parent company was 4.7244 million yuan, indicating a turnaround from a loss compared to the same period last year [1] Investment and Consolidation - The increase in net profit is primarily attributed to the company's increased stake in Boling Brain Machine and the subsequent inclusion of this company in the consolidated financial statements [1] - According to the relevant accounting standards, this consolidation led to the recognition of corresponding investment income, positively impacting net profit and related financial metrics compared to the previous year [1]
创新医疗前三季度净利472.44万元,同比扭亏